Cairo - Mubasher: LVP Pharma raised its ownership in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) to 23.15% from 12% at a value of EGP 1.13 billion, according to a bourse filing.
The firm acquired 223 million shares, of which 220 million belonged to Equinox Pharma Holding, at an average price of EGP 5.09 per share.
Last February, LVP Pharma hiked its stake to 11.76% from 9.22% after purchasing 51.52 million shares in the EGX-listed company.
